View More Recent Stories

Dec 9, 2024 07:12AM BioAge Labs (BIOA) Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity

Dec 9, 2024 05:01AM Citi Downgrades BioAge Labs Inc (BIOA) to Neutral

Dec 9, 2024 03:00AM Jefferies Downgrades BioAge Labs Inc (BIOA) to Hold

Oct 21, 2024 07:26AM Citi Starts BioAge Labs Inc (BIOA) at Buy

Oct 21, 2024 03:37AM Jefferies Starts BioAge Labs Inc (BIOA) at Buy

Oct 21, 2024 01:37AM Morgan Stanley Starts BioAge Labs Inc (BIOA) at Overweight

Sep 26, 2024 12:16PM BioAge Labs (BIOA) opens at $22.50, IPO priced at $18

Sep 26, 2024 12:15PM Bioage Labs (BIOA) Opens At $22.50, IPO Priced At $18

Sep 26, 2024 06:03AM BioAge Labs (BIOA) Announces Upsized 11M Share Offering at $18/sh

Sep 25, 2024 06:20AM BioAge Labs (BIOA) Upsizes Proposed IPO to 10.5M Shares at $17-$19/sh

Sep 18, 2024 04:07PM BioAge Labs (BIOA) Announces 7.5M Share IPO at $17-$19/sh

Sep 3, 2024 04:05PM BioAge Labs (BIOA) Files for Proposed IPO

View More Recent Stories